{"transactions":[{"id":4638345,"issuer":{"id":184308,"kind":"organization","name":"TRex Bio, Inc.","symbol":"TRXB"},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-09T01:50:46.000Z","date":"2026-10-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on October 8, 2027, subject to the reporting person's continued service through such date."}],"balance_after":17500,"derivative":{"exercise_price":14,"expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001193125-26-418293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2139097/000119312526418293/ownership.xml","form_type":"4"}},{"id":724124,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-29T20:35:55.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":5860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":5860,"derivative":{"exercise_price":5.5,"expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":5860},"source":{"system":"sec-edgar","filing":"0001610717-26-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000161071726000300/form4.xml","form_type":"4"}},{"id":1101104,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-26T20:30:36.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":5860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2026 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":5860,"derivative":{"exercise_price":7.63,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":5860},"source":{"system":"sec-edgar","filing":"0001610717-25-000257","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000161071725000257/form4.xml","form_type":"4"}},{"id":1119910,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:26:55.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":35144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":35144,"derivative":{"exercise_price":1.5,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":35144},"source":{"system":"sec-edgar","filing":"0000905148-25-002032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514825002032/form4.xml","form_type":"4"}},{"id":1467297,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T20:08:43.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2025 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-24-000372","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000161071724000372/form4.xml","form_type":"4"}},{"id":1485093,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:07:03.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":7250,"derivative":{"exercise_price":72.51,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001649094-24-000010","document":"wk-form4_1718050014.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000164909424000010/wk-form4_1718050014.xml","form_type":"4"}},{"id":1485092,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:07:03.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":7175,"source":{"system":"sec-edgar","filing":"0001649094-24-000010","document":"wk-form4_1718050014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000164909424000010/wk-form4_1718050014.xml","form_type":"4"}},{"id":1487113,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:17:32.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":45642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":45642,"derivative":{"exercise_price":1.25,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":45642},"source":{"system":"sec-edgar","filing":"0000905148-24-001685","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514824001685/form4.xml","form_type":"4"}},{"id":1612511,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:35:02.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":4411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's shares granted to the reporting person on June 17, 2021. In exchange, on February 28, 2024, the reporting person received a replacement option, for 4,411 shares, having an exercise price of $0.96 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":4411,"derivative":{"exercise_price":0.96,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":4411},"source":{"system":"sec-edgar","filing":"0001610717-24-000102","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000161071724000102/form4.xml","form_type":"4"}},{"id":1612510,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:35:02.000Z","date":"2024-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's shares granted to the reporting person on June 17, 2021. In exchange, on February 28, 2024, the reporting person received a replacement option, for 4,411 shares, having an exercise price of $0.96 per share."}],"balance_after":0,"derivative":{"exercise_price":26.58,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001610717-24-000102","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000161071724000102/form4.xml","form_type":"4"}},{"id":1824907,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-21T20:13:55.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2024 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1,"expiration_date":"2033-07-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-23-000213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000161071723000213/form4.xml","form_type":"4"}},{"id":1854557,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T21:53:24.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":15000,"derivative":{"exercise_price":53.08,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-037502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000120919123037502/doc4.xml","form_type":"4"}},{"id":1854556,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:53:24.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001209191-23-037502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000120919123037502/doc4.xml","form_type":"4"}},{"id":1857409,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T23:54:37.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":41533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 8, 2024, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":41533,"derivative":{"exercise_price":2.075,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":41533},"source":{"system":"sec-edgar","filing":"0001140361-23-029696","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123029696/form4.xml","form_type":"4"}},{"id":2221278,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-27T20:14:08.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2023 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-22-013391","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000156761922013391/doc1.xml","form_type":"4"}},{"id":2245042,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:30:24.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":18750,"derivative":{"exercise_price":22.7,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-22-034052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000120919122034052/doc4.xml","form_type":"4"}},{"id":2245041,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:30:24.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-22-034052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000120919122034052/doc4.xml","form_type":"4"}},{"id":2251622,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T23:42:07.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":23885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on May 26, 2023, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":23885,"derivative":{"exercise_price":4.85,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":23885},"source":{"system":"sec-edgar","filing":"0001567619-22-011963","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000156761922011963/doc1.xml","form_type":"4"}},{"id":2521585,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-08T23:35:13.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":34731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest annually over three years from the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":34731,"derivative":{"exercise_price":14,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":34731},"source":{"system":"sec-edgar","filing":"0001140361-21-037040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036121037040/form4.xml","form_type":"4"}},{"id":2664079,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T21:13:17.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual meeting in 2022 of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":26.58,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-012337","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000156761921012337/doc1.xml","form_type":"4"}},{"id":2683634,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":34844,"kind":"person","name":"Hirth Peter","position":1,"cik":"0001813780","reported_name":"Hirth Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-03T22:50:54.000Z","date":"2021-06-02","kind":"grant","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly and fully vest on the earlier of June 2, 2022 or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date."}],"balance_after":15000,"derivative":{"exercise_price":21.49,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-037901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813780/000120919121037901/doc4.xml","form_type":"4"}}]}